Reza Afkhami
Corporate Officer/Principal en 23ANDME HOLDING CO. .
Perfil
Reza Afkhami is currently the Chief Corporate Development Officer at 23andMe, Inc. and 23andMe Holding Co. He previously worked as the Senior VP-Corporate Development & Strategy at Global Blood Therapeutics, Inc. and as the Vice President-Corporate Development & Strategy at Surrozen, Inc. Afkhami holds an MBA from the University of California, Berkeley and an undergraduate degree from Georgetown University.
Cargos activos de Reza Afkhami
| Empresas | Cargo | Inicio |
|---|---|---|
| 23ANDME HOLDING CO. | Corporate Officer/Principal | 08/05/2023 |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01/05/2023 |
Antiguos cargos conocidos de Reza Afkhami.
| Empresas | Cargo | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2023 |
| SURROZEN, INC. | Corporate Officer/Principal | 01/01/2022 |
Formación de Reza Afkhami.
| University of California, Berkeley | Masters Business Admin |
| Georgetown University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SURROZEN, INC. | Health Technology |
| 23ANDME HOLDING CO. | Health Technology |
| Empresas privadas | 2 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Reza Afkhami
